This document discusses tricyclic antidepressant (TCA) toxicity from overdose or drug interactions. It outlines the clinical features and timeline of TCA toxicity, which include early anticholinergic effects followed later by myocardial depression, seizures, and arrhythmias. Diagnostic testing includes ECG and urine drug screens. Management involves stabilizing the patient, administering activated charcoal, fluid resuscitation, vasopressors if hypotensive, benzodiazepines for seizures, and other interventions depending on symptoms. Patients exhibiting signs of TCA toxicity such as arrhythmias or seizures require ICU admission.